SEC Company Response from Microbot Medical Inc. (MBOT) (CIK 0000883975) (MBOT) — Jun 10, 2010
Microbot Medical Inc. (MBOT) (CIK 0000883975)
Date: June 10, 2010 · CIK: 0000883975 · Accession: 0000950123-10-057332
AI Filing Summary & Sentiment
File numbers found in text: 001-19871
Referenced dates: June 7, 2010
Letter
June 10, 2010
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-7010
Attention:
Frank Wyman
Lisa Vanjoske
Karen Ubell
Suzanne Hayes
Jim B. Rosenberg
Re:
SEC Comment Letter dated June 7, 2010
StemCells, Inc.
Form 10-K for the fiscal year ended December 31, 2009
Definitive Proxy Statement on Schedule 14A filed April 13, 2010
File No. 001-19871
Ladies and Gentlemen:
This letter is to confirm my telephone conversation yesterday with Mr. Wyman of staff of the Securities and Exchange Commission wherein I advised Mr. Wyman that our response to the staff’s comment later dated June 7, 2010 would be provided by July 6, 2010.
Very truly yours,
/s/ Kenneth B. Stratton
Show Raw Text
CORRESP
1
filename1.htm
corresp
June 10, 2010
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-7010
Attention:
Frank Wyman
Lisa Vanjoske
Karen Ubell
Suzanne Hayes
Jim B. Rosenberg
Re:
SEC Comment Letter dated June 7, 2010
StemCells, Inc.
Form 10-K for the fiscal year ended December 31, 2009
Definitive Proxy Statement on Schedule 14A filed April 13, 2010
File No. 001-19871
Ladies and Gentlemen:
This letter is to confirm my telephone conversation yesterday with Mr. Wyman of staff of the
Securities and Exchange Commission wherein I advised Mr. Wyman that our response to the staff’s
comment later dated June 7, 2010 would be provided by July 6, 2010.
Very truly yours,
/s/ Kenneth B. Stratton
Kenneth B. Stratton
General Counsel
StemCells, Inc.